Skip to content
Trial Eligibility
Menu

Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version

NCT07092527

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This research study investigates whether male-level exogenous androgens inhibit the reproductive neuroendocrine axis in otherwise healthy (non-PCOS) females.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Transgenderism
  • Reproductive Issues

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 to 35 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
University of California, San Diego
Last updated on ClinicalTrials.gov
January 15, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • University of California, San Diego · San Diego, CA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.